At the time of writing, Elevance Health Inc [ELV] stock is trading at $277.09, down -8.38%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ELV shares have lost -18.66% over the last week, with a monthly amount drifted -26.15%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elevance Health Inc [NYSE: ELV] stock has seen the most recent analyst activity on July 18, 2025, when Leerink Partners downgraded its rating to a Market Perform but kept the price target unchanged to $310 for it. Previously, Robert W. Baird downgraded its rating to Neutral on April 15, 2025, and kept the price target unchanged to $529. On March 17, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $450 on the stock. Stephens downgraded its rating to a Equal-Weight and decreased its price target to $440 on January 22, 2025. Argus downgraded its rating to a Hold. BofA Securities downgraded its rating to Neutral for this stock on July 18, 2024, and downed its price target to $530. In a note dated June 24, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $643 on this stock.
For the past year, the stock price of Elevance Health Inc fluctuated between $296.39 and $567.26. Currently, Wall Street analysts expect the stock to reach $482.5 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $277.09 at the most recent close of the market. An investor can expect a potential return of 74.13% based on the average ELV price forecast.
Analyzing the ELV fundamentals
According to Elevance Health Inc [NYSE:ELV], the company’s sales were 189.25B for trailing twelve months, which represents an 14.04% jump. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.4%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.14 and Total Capital is 1.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 271.23 points at the first support level, and at 265.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 288.13, and for the 2nd resistance point, it is at 299.17.
Ratios To Look Out For
It is important to note that Elevance Health Inc [NYSE:ELV] has a current ratio of 1.44. Considering the valuation of this stock, the price to sales ratio is 0.33, the price to book ratio is 1.42 and price to earnings (TTM) ratio is 11.79.
Transactions by insiders
Recent insider trading involved BOUDREAUX GAIL, President and CEO, that happened on Jul 18 ’25 when 8500.0 shares were purchased. EVP & CFO, Kaye Mark completed a deal on Apr 24 ’25 to sell 4588.0 shares. Meanwhile, Officer Kaye Mark bought 4588.0 shares on Apr 24 ’25.
